These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2501532)
1. Detection of impaired fibrinolytic activity in coronary artery disease--electrophoretic and immuno-blotting analysis of tissue plasminogen activator. Uno M; Tsuji H; Watanabe M; Takabuchi H; Kobayashi K; Shirai K; Sawada S; Toyoda T; Nakagawa M Jpn Circ J; 1989 Mar; 53(3):229-36. PubMed ID: 2501532 [TBL] [Abstract][Full Text] [Related]
2. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. Wun TC; Capuano A Blood; 1987 May; 69(5):1354-62. PubMed ID: 3105619 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963 [TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor. Hersch SL; Kunelis T; Francis RB Blood; 1987 May; 69(5):1315-9. PubMed ID: 2436684 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy. Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of fibrinolytic factors in coronary heart disease. Wiman B Scand J Clin Lab Invest Suppl; 1999; 230():23-31. PubMed ID: 10389198 [TBL] [Abstract][Full Text] [Related]
8. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970 [TBL] [Abstract][Full Text] [Related]
9. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity]. Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860 [TBL] [Abstract][Full Text] [Related]
10. Identification and regulation of tissue plasminogen activator activity in rat cumulus-oocyte complexes. Liu YX; NY T; Sarkar D; Loskutoff D; Hsueh AJ Endocrinology; 1986 Oct; 119(4):1578-87. PubMed ID: 3093195 [TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic responses of human peritoneal fluid in laparoscopic cholecystectomy: a prospective clinical study. Tarhan OR; Barut I; Akdeniz Y; Sutcu R; Cerci C; Bulbul M Surg Endosc; 2008 Apr; 22(4):1008-13. PubMed ID: 17763904 [TBL] [Abstract][Full Text] [Related]
12. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039 [TBL] [Abstract][Full Text] [Related]
13. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Estellés A; Tormo G; Aznar J; España F; Tormo V Thromb Res; 1985 Nov; 40(3):373-83. PubMed ID: 4082114 [TBL] [Abstract][Full Text] [Related]
19. Immunoradiometric quantitation of tissue plasminogen activator-related antigen in human plasma: crypticity phenomenon and relationship to plasma fibrinolysis. Wun TC; Capuano A Blood; 1987 May; 69(5):1348-53. PubMed ID: 3105618 [TBL] [Abstract][Full Text] [Related]
20. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis. Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]